Literature DB >> 3655306

Repeated paracentesis and i.v. albumin infusion to treat 'tense' ascites in cirrhotic patients. A safe alternative therapy.

F Salerno1, S Badalamenti, P Incerti, S Tempini, B Restelli, S Bruno, G Bellati, L Roffi.   

Abstract

To investigate the usefulness of paracentesis as an alternative treatment for ascites, 41 cirrhotic patients with 'tense' ascites were randomly assigned to treatment with either repeated paracenteses plus i.v. albumin infusion (n = 20) or diuretics (n = 21). Satisfactory mobilization of ascites was obtained with paracentesis in all but one case and with diuretics in all but two cases. Ascites disappeared within 3 or 4 days with paracentesis, but only after 15 days with diuretics. The rate of reaccumulation of ascites following paracentesis, without diuretic administration, exceeded 300 g/day in only 5 patients. The incidence of complications and the mortality rate were similar in both groups of patients during hospital stay and during follow-up. This was corroborated by the evidence that no negative changes were induced in clinical and laboratory parameters of hemodynamic, hepatic and renal function after evacuation of the ascites. These results confirm that repeated paracenteses combined with human albumin replacement are safe and effective for treating 'tense' ascites, and more rapid than traditional diuretic therapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3655306     DOI: 10.1016/s0168-8278(87)80067-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  20 in total

1.  Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites.

Authors:  G Nasr; A Hassan; S Ahmed; A Serwah
Journal:  J Cardiovasc Dis Res       Date:  2010-07

2.  Guidelines on the management of ascites in cirrhosis.

Authors:  K P Moore; G P Aithal
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

3.  Comparison of spontaneous ascites filtration and reinfusion with total paracentesis with intravenous albumin infusion in cirrhotic patients with tense ascites.

Authors:  S Bruno; M Borzio; M Romagnoni; P M Battezzati; S Rossi; A Chiesa; M Podda
Journal:  BMJ       Date:  1992-06-27

4.  A survey of treatment approaches of malignant ascites in Germany and Austria.

Authors:  C F Jehn; S Küpferling; G Oskay-Özcelik; D Lüftner
Journal:  Support Care Cancer       Date:  2014-12-21       Impact factor: 3.603

Review 5.  Malignant ascites: pathophysiology and treatment.

Authors:  Emanuel Cavazzoni; Walter Bugiantella; Luigina Graziosi; Maria Silvia Franceschini; Annibale Donini
Journal:  Int J Clin Oncol       Date:  2012-03-31       Impact factor: 3.402

6.  Reinfusion of concentrated ascitic fluid versus total paracentesis. A randomized prospective trial.

Authors:  A Graziotto; L Rossaro; P Inturri; M Salvagnini
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

7.  Concentrated ascitic fluid reinfusion after cascade filtration in tense ascites.

Authors:  L Rossaro; A Graziotto; S Bonato; M Plebani; D H van Thiel; A Burlina; R Naccarato; M Salvagnini
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

8.  Palliative treatment of malignant ascites: profile of catumaxomab.

Authors:  Lila Ammouri; Eric E Prommer
Journal:  Biologics       Date:  2010-05-25

9.  Dextran administration avoids hemodynamic changes following paracentesis in cirrhotic patients. A safe and inexpensive option.

Authors:  R Terg; J Berreta; R Abecasis; G Romero; L Boerr
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

Review 10.  Pharmacotherapy of ascites associated with cirrhosis.

Authors:  P Ginès; V Arrovo; J Rodés
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.